Title for MeetingAbstracts
Alphabetical listing of titles
Novel Method of HIV-1 Inactivation and Its Application towards Development of a Whole-Killed HIV Vaccine.
Novel method of Inactivation of HIV-1 by the freeze pressure generation method (FPGM).
Novel method to detect transcriptionally active HIV particles.
Novel method to probe the structural response of individual cells to externally applied mechanical stress.
Novel methods for the rescue, detection and quantification of cell-free HIV-1 RNA and its application in zidovudine resistance studies.
Novel Methods to Make Cholera Toxin-Like Chimeras as Vaccines and Molecular Reagents.
Novel microarray hybridization technique for testing HIV protease inhibitors resistance.
Novel mode of HIV replication in persistently infected monocytoid cells: accumulation of self-integrated, extrachromosomal proviruses leads to the production of defective virions.
Novel muramyl tripeptide (MTP-PE) adjuvant formulations for enhancement of immunity to recombinant HIV-1 gp120 envelope antigens.
Novel mutation associated with HIV-1 resistance to AZT.
Novel mutation sites in reverse transcriptase (RT) of AZT-resistant HIV-1 map to the active site of an RT model.
Novel mutations associated with HIV-1 resistance to AZT.
Novel Mutations in fusA that Confer Fusidic Acid Resistance in Staphylococcus aureus.
Novel Mutations in HIV-1 Integrase Associated with Resistance to Diketo Acids.
Novel mutations in HIV-1 reverse transcriptase cause resistance to foscarnet in laboratory and clinical isolates.
Novel mutations in HIV-1 reverse transcriptase selected for by 2',3'-dideoxy, 2',3'-didehydro-beta-5-fluorocytidine, a potent inhibitor of HIV-1.
Novel Mutations in Loci Associated with Fluoroquinolone Resistance in Streptococcus pneumoniae.
Novel Mutations in the Herpes Simplex Virus Type 1 (HSV-1) DNA Polymerase Confer Resistance to (S)-3-Hydroxy-2-Phosphonylmethoxypropyl (HPMP) Derivatives of Cytosine (HPMPC, Cidofovir) and Adenine (HPMPA).
Novel Mutations in the Promoter and Attenuator Regions of Hyperproducing AmpC E. coli Strains from China.
Novel Nitrofuran-Like Antimicrobial Agents against Biodefense Organisms.
Novel Non-CFTR-Dependent Pseudomonas aeruginosa Epithelial Internalization Results in Intracellular Bacterial Replication and Transmigration without Host Cell Death.
Novel non-nucleoside compound with in vitro anti-HIV-1 activity.
Novel Non-Nucleosidic and Highly Potent Inhibitors of Human Hepatitis B Virus (HBV): Synthesis and Structure Activity Relationship (SAR) of Chromanones (Part 2).
Novel Non-Nucleosidic and Highly Potent Inhibitors of Human Hepatitis B Virus (HBV): Synthesis and Structure Activity Relationship (SAR) of Isoxazole 4-Carboxamides and Other Bisaryl Amides (Part 1).
Novel Non-Nucleosidic and Highly Potent Inhibitors of Human Hepatitis B Virus: Antiviral Profile of the Most Potent Inhibitors out of the Class of Isoxazole-4-Carboxamides and Chromanones (Part 3).
Novel non-peptide inhibitors of HIV protease: effects on viral polyprotein processing and virus morphology.
Novel non-peptide inhibitors of HIV protease: effects on viral polyprotein processing and virus morphology.
Novel non-peptide inhibitors of HIV protease: potency, specificity and bioavailability.
Novel non-peptide inhibitors of HIV protease: three dimensional structure of the complex by X-ray crystallography.
Novel non-peptidic HIV protease inhibitors by computer assisted molecular design. Part 1: Synthesis and biological activity of a polyfunctional piperidine.